X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (843) 843
Publication (69) 69
Book Review (8) 8
Book Chapter (5) 5
Conference Proceeding (4) 4
Magazine Article (3) 3
Data Set (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (750) 750
aminoquinolines - adverse effects (502) 502
female (469) 469
male (451) 451
aminoquinolines - therapeutic use (408) 408
index medicus (373) 373
aminoquinolines - administration & dosage (365) 365
imiquimod (317) 317
middle aged (294) 294
dermatology (281) 281
adult (278) 278
treatment outcome (230) 230
aged (222) 222
administration, topical (198) 198
skin neoplasms - drug therapy (169) 169
animals (159) 159
antineoplastic agents - adverse effects (143) 143
adjuvants, immunologic - adverse effects (140) 140
antineoplastic agents - administration & dosage (136) 136
antineoplastic agents - therapeutic use (134) 134
adjuvants, immunologic - administration & dosage (120) 120
adjuvants, immunologic - therapeutic use (115) 115
aminoquinolines - pharmacology (104) 104
aged, 80 and over (102) 102
care and treatment (97) 97
mice (93) 93
carcinoma, basal cell - drug therapy (92) 92
adolescent (89) 89
administration, cutaneous (88) 88
double-blind (80) 80
skin (77) 77
double-blind method (76) 76
5-percent cream (72) 72
skin neoplasms - pathology (72) 72
drug therapy (71) 71
immunology (70) 70
dose-response relationship, drug (69) 69
drug administration schedule (66) 66
research (64) 64
therapy (64) 64
infectious diseases (62) 62
ointments (62) 62
condylomata acuminata - drug therapy (61) 61
follow-up studies (60) 60
cancer (59) 59
pharmacology & pharmacy (58) 58
dosage and administration (56) 56
actinic keratosis (52) 52
malaria (51) 51
psoriasis (51) 51
topical imiquimod (50) 50
surgery (49) 49
immune-response modifier (47) 47
keratosis, actinic - drug therapy (47) 47
antimalarials - adverse effects (46) 46
carcinoma, basal cell - pathology (46) 46
disease models, animal (46) 46
inflammation (46) 46
interferon inducers - adverse effects (46) 46
skin cancer (46) 46
time factors (46) 46
young adult (46) 46
child (45) 45
health aspects (45) 45
keratosis - drug therapy (44) 44
skin - pathology (44) 44
aminoquinolines - pharmacokinetics (43) 43
analysis (43) 43
cream (43) 43
trial (43) 43
oncology (42) 42
primaquine (42) 42
prospective studies (41) 41
psoriasis - chemically induced (40) 40
interferon inducers - therapeutic use (39) 39
interferon inducers - administration & dosage (37) 37
prolactin - blood (37) 37
efficacy (36) 36
basal cell carcinoma (35) 35
carcinoma, squamous cell - drug therapy (35) 35
safety (35) 35
medicine, general & internal (34) 34
endocrinology & metabolism (33) 33
expression (33) 33
immunotherapy (33) 33
mice, inbred c57bl (33) 33
article (32) 32
basal-cell carcinoma (32) 32
biopsy (32) 32
dopamine agonists - therapeutic use (32) 32
drug eruptions - etiology (32) 32
antimalarials - therapeutic use (31) 31
disease (31) 31
genital warts (31) 31
psoriasis - pathology (31) 31
randomized controlled trials as topic (31) 31
pituitary neoplasms - drug therapy (30) 30
retrospective studies (30) 30
bromocriptine - therapeutic use (29) 29
carcinoma in situ - drug therapy (29) 29
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (804) 804
French (14) 14
German (7) 7
Russian (7) 7
Spanish (7) 7
Japanese (2) 2
Bulgarian (1) 1
Chinese (1) 1
Danish (1) 1
Hungarian (1) 1
Portuguese (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Proceedings of the National Academy of Sciences of the United States of America, ISSN 0027-8424, 10/2013, Volume 110, Issue 43, pp. 17486 - 17491
Individuals with glucose 6-phosphate dehydrogenase (G6PD) deficiency are at risk for the development of hemolytic anemia when given 8-aminoquinolines (8-AQs),... 
Hemolysis | Dehydrogenases | Malaria | Erythrocytes | Antimalarials | Mice | Drug design | Reticulocytes | Dosage | Blood | IMMUNOCOMPROMISED MICE | IMMUNODEFICIENT MICE | DRUG | TRANSMISSION | HUMAN MALARIA | SCID MICE | PLASMODIUM-FALCIPARUM | HUMAN ERYTHROCYTES | MULTIDISCIPLINARY SCIENCES | RED-BLOOD-CELLS | PRIMAQUINE | Dapsone - adverse effects | Humans | Transplantation, Heterologous | Dapsone - therapeutic use | Erythrocyte Transfusion - methods | Dose-Response Relationship, Drug | Mefloquine - therapeutic use | Sensitivity and Specificity | Female | Doxycycline - adverse effects | Pyrimethamine - therapeutic use | Antimalarials - adverse effects | Drug Evaluation, Preclinical - methods | Reproducibility of Results | Glucosephosphate Dehydrogenase Deficiency - blood | Pyrimethamine - adverse effects | Doxycycline - therapeutic use | Glucosephosphate Dehydrogenase Deficiency - therapy | Chloroquine - therapeutic use | Antimalarials - therapeutic use | Combined Modality Therapy | Chloroquine - adverse effects | Mice, SCID | Mefloquine - adverse effects | Animals | Primaquine - therapeutic use | Anemia, Hemolytic - diagnosis | Anemia, Hemolytic - chemically induced | Mice, Inbred NOD | Primaquine - adverse effects | Anemia, Hemolytic - blood | Aminoquinolines - therapeutic use | Erythrocyte Count | Aminoquinolines - adverse effects | Phosphates | Physiological aspects | Oxidoreductases | Anemia | Health aspects | Risk factors | Index Medicus | Biological Sciences
Journal Article
British Journal of Dermatology, ISSN 0007-0963, 12/2007, Volume 157, Issue s2, pp. 34 - 40
Journal Article
Nature Communications, ISSN 2041-1723, 2013, Volume 4, Issue 1, p. 1560
Journal Article
Journal Article
British Journal of Dermatology, ISSN 0007-0963, 05/2017, Volume 176, Issue 5, pp. 1148 - 1154
Journal Article
Journal Article
Journal of Immunology, ISSN 0022-1767, 01/2012, Volume 188, Issue 1, pp. 462 - 469
Psoriasis is a common chronic autoimmune skin disease of unknown cause that involves dysregulated interplay between immune cells and keratinocytes. IL-22 is a... 
ROR-GAMMA-T | DENDRITIC CELLS | DOUBLE-BLIND | INTERLEUKIN-22 | CYTOKINE | IMMUNOLOGY | EXPRESSION | 5-PERCENT CREAM | ACTINIC KERATOSIS | INNATE IMMUNITY | TH17 CELLS | Adjuvants, Immunologic - pharmacology | Chemokine CCL3 - immunology | Dermatitis - immunology | Skin - metabolism | Immunity, Innate - genetics | Receptors, Antigen, T-Cell, gamma-delta - genetics | Adjuvants, Immunologic - adverse effects | Interleukins - genetics | Chemokine CCL3 - genetics | Psoriasis - pathology | T-Lymphocytes - metabolism | Interleukins - immunology | Psoriasis - metabolism | Antigens, Differentiation - metabolism | Chemokine CCL3 - metabolism | Interleukins - biosynthesis | T-Lymphocytes - pathology | Aminoquinolines - pharmacology | Neutrophils - metabolism | Neutrophil Infiltration - drug effects | Skin - pathology | Disease Models, Animal | Neutrophil Infiltration - immunology | Neutrophils - pathology | Skin - immunology | Psoriasis - immunology | Immunity, Innate - drug effects | Receptors, Antigen, T-Cell, gamma-delta - metabolism | Gene Expression Regulation - genetics | Gene Expression Regulation - immunology | Neutrophils - immunology | Receptors, Antigen, T-Cell, gamma-delta - immunology | Neutrophil Infiltration - genetics | Mice, Knockout | Dermatitis - etiology | Immunity, Innate - immunology | Animals | Psoriasis - chemically induced | T-Lymphocytes - immunology | Antigens, Differentiation - genetics | Mice | Aminoquinolines - adverse effects | Antigens, Differentiation - immunology | Dermatitis - metabolism
Journal Article
The Journal of Immunology, ISSN 0022-1767, 07/2008, Volume 181, Issue 1, pp. 776 - 784
Journal Article